Next-generation targeting for evolving HCP engagement
The days of solely relying on prescription data and manual sales alignments are fading fast as the pharmaceutical industry enters a new era of HCP engagement.
Corporate Governance
3 reasons why biotechs preparing for launch need a compliant content foundation
Mastering compliance and copyright in healthcare and MedComms
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
JP Morgan 2025: Incyte expects period of ‘defining catalysts’
FDA CDER director Patrizia Cavazzoni announces resignation
Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
